The UK's Pay-or-Play Solution: A Horribly Flawed Idea

Posted by Ed Schoonveld on Fri, May 20, 2016

We desperately need new anti-infective drugs to avoid life threatening infections! Let’s make that happen by punishing companies who don’t invest in R&D for these specific drugs.

No, this is not a bad joke, but rather a slightly paraphrased recommendation of a U.K. government-commissioned Review of Antimicrobial Resistance (AMR). Let’s look at the details.

Read More